Evaluation of Asprosin Levels in Polycystic Ovary Syndrome and Its Association with Fetuin A and Some Biochemical Parameters
August 2023
in “
South Asian Research Journal of Pharmaceutical Sciences
”
Studysummary This study examined the relationship between asprosin levels and polycystic ovary syndrome, finding no statistically significant difference in asprosin levels between patients and healthy controls, although differences in fetuin a levels were significant.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This study evaluated the levels of asprosin and fetuin A in women with Polycystic Ovary Syndrome (PCOS) and their association with various biochemical parameters. It involved 90 participants, with 60 women diagnosed with PCOS and 30 healthy controls. The findings revealed that fetuin A levels were significantly higher in PCOS patients compared to controls, suggesting its potential role in the metabolic profile of PCOS. In contrast, asprosin levels did not differ significantly between the groups, indicating it may not be useful for diagnosing PCOS. Additionally, significant differences in fasting blood sugar, insulin, cholesterol, and triglyceride levels were observed, highlighting metabolic disruptions in PCOS patients.
